Stocktoria

AVAI BIO, INC. AVAI

OTC · stock · Services-Computer Processing & Data Preparation · website · IPO 2019-05-02

AVAI BIO, INC. financials (annual)

Revenue
$276324 201920202021202220232023202420252026
Net income
-$78225 -$69593 -$248022 -$348933 -$1.8M -$2.1M -$1.1M -$1.7M 201920202021202220232023202420252026
Free cash flow
201920202021202220232023202420252026

Bars are annual figures from 2019 to 2026; red bars are negative (a loss or cash outflow).

MetricFY2026FY2025FY2024FY2023FY2023FY2022FY2021FY2020FY2019
Revenue————$276,324————
Gross profit————-$40,453$210,794-$16,536$256,334$0
R&D expense$15,000——————$27,040$0
Operating income-$1.7M-$1.1M-$2.1M—-$348,933$126,521$302,292-$69,593-$78,225
Net income-$1.7M-$1.1M-$2.1M-$1.8M-$348,933—-$248,022-$69,593-$78,225
Operating cash flow-$1.0M-$1.2M-$1.3M—-$54,457$535,008-$16,169$130,718-$84,165
Cash & equivalents$23,145$81,053$281$896$107,472$33,289$60,364$27,301$102
Total assets$572,696$224,745$322,014$291,246$241,460$454,664$816,269$419,971$30,523
Total liabilities$3.4M$1.8M$1.8M$1.7M$874,719$860,225$1.1M-$37,686$30,523
Shareholders' equity-$2.8M-$1.6M-$1.5M-$1.4M-$633,259-$405,561-$327,413-$37,686-$49,612

Computed from company filings · US · as of 2025-03-31. Facts plus Stocktoria's own computed scores — not investment advice.